Title : A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer.

Pub. Date : 2012 Feb

PMID : 22102173






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
2 PURPOSE: To investigate the association between a single-nucleotide polymorphism (SNP) of ERCC1, Asn118Asn (C T), and the response of patients with late-stage non-small cell lung cancer (NSCLC) (n = 142) to cisplatin-based chemotherapy. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
3 CONCLUSIONS: Our results suggest that this polymorphism of ERCC1 at codon 118 is associated with patient response to cisplatin-based chemotherapy in treatments of late-stage NSCLC. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens